The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced resectable esophageal squamous cell carcinoma: A prospective phase 2 study.
 
Haiping Jiang
No Relationships to Disclose
 
Peng Ye
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Hui Wu
No Relationships to Disclose
 
Yongfeng Ding
No Relationships to Disclose
 
Xin Xu
No Relationships to Disclose
 
Ying Ma
No Relationships to Disclose
 
Xiao-Dong Teng
No Relationships to Disclose
 
Songxiao Ji
Employment - Department of Medical Affairs, Innovent Biologics, Inc, Suzhou, China
Honoraria - Department of Medical Affairs, Innovent Biologics, Inc, Suzhou, China
 
Jingjie Li
Employment - Department of Medical Affairs, Innovent Biologics, Inc, Suzhou, China
Honoraria - Department of Medical Affairs, Innovent Biologics, Inc, Suzhou, China